Observatory of Patients With Chronic Lymphocytic Leukemia / Lymphocytic Lymphoma or Waldenstrom Disease Infected With COVID-19

CompletedOBSERVATIONAL
Enrollment

162

Participants

Timeline

Start Date

March 14, 2020

Primary Completion Date

March 10, 2022

Study Completion Date

March 10, 2023

Conditions
Chronic Lymphocytic Leukemia, Lymphocytic Lymphoma or Waldenstrom Disease
Interventions
BEHAVIORAL

Data registry

Collection of clinical data, treatment regimens and survival data

Trial Locations (22)

25000

CHU Jean Minjoz - Hématologie, Besançon

31059

IUCT ONCOPOLE - Hématologie, Toulouse

37044

Hôpital Bretonneau - Hématologie et Thérapie Cellulaire, Tours

44093

CHU DE NANTES - Hematologie clinique, Nantes

49933

Chu Angers, Angers

51092

Hôpital Robert Debré - Hématologie Clinique, Reims

54500

CHU Nancy Brabois, Vandœuvre-lès-Nancy

59000

Hôpital Saint Vicent de Paul, Lille

63000

CHU Estaing - Hématologie Clinique Adulte, Clermont-Ferrand

67098

Hôpital Hautepierre - Hématologie, Strasbourg

68100

Hopital E.Muller, Mulhouse

69373

Centre Léon Bérard - Hématologie, Lyon

69495

Centre Hospitalier Lyon Sud, Pierre-Bénite

72000

Centre Hospitalier du Mans, Le Mans

75651

Hopital Pitie Salpetriere Service Hematologie Clinique - Pavillon de L'Enfant Et Adolescent, Paris

76038

Centre Henri Becquerel - Service Hématologie Clinique, Rouen

85925

Chd Vendee, La Roche-sur-Yon

86021

Hôpital de la Milétrie - Hématologie et Thérapie Cellulaire, Poitiers

93009

Hôpital Avicenne - Centre de Recherche Clinique, Bobigny

94000

Chu Creteil, Créteil

130009

Institut Paoli Calmette, Marseille

388043

CHU Grenoble - Hématologie, Grenoble

All Listed Sponsors
collaborator

Institut de cancérologie Strasbourg Europe

OTHER

lead

French Innovative Leukemia Organisation

OTHER

NCT04391946 - Observatory of Patients With Chronic Lymphocytic Leukemia / Lymphocytic Lymphoma or Waldenstrom Disease Infected With COVID-19 | Biotech Hunter | Biotech Hunter